These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15229983)

  • 21. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM; Fleischmann RM; Van der Heijde D; Tesser JR; Peloso PM; Chon Y; White B
    J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
    Malesci D; La Montagna G
    Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-tumor necrosis factor-alpha-induced psoriasis.
    Sari I; Akar S; Birlik M; Sis B; Onen F; Akkoc N
    J Rheumatol; 2006 Jul; 33(7):1411-4. PubMed ID: 16821276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasiform and pustular eruption induced by etanercept and infliximab.
    Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
    Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
    Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
    [No Abstract]   [Full Text] [Related]  

  • 27. Is there a link between the use of etanercept and Henoch-Schönlein purpura? Comment on: Henoch-Schonlein purpura in a patient with the rheumatoid arthritis receiving etanercept (Eur J Dermatol 2010; 20: 521-2).
    Park SJ; Kim JH; Shin JI
    Eur J Dermatol; 2011; 21(1):147. PubMed ID: 21227894
    [No Abstract]   [Full Text] [Related]  

  • 28. Phlegmonous abscess associated with etanercept therapy.
    D'Amore M; Minenna G; Favoino E; D'Amore S
    Panminerva Med; 2006 Sep; 48(3):199-200. PubMed ID: 17122757
    [No Abstract]   [Full Text] [Related]  

  • 29. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical infection with Strongyloides sterocoralis following etanercept use for rheumatoid arthritis.
    Boatright MD; Wang BW
    Arthritis Rheum; 2005 Apr; 52(4):1336-7. PubMed ID: 15818680
    [No Abstract]   [Full Text] [Related]  

  • 31. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
    Moreland LW; Weinblatt ME; Keystone EC; Kremer JM; Martin RW; Schiff MH; Whitmore JB; White BW
    J Rheumatol; 2006 May; 33(5):854-61. PubMed ID: 16541481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage activation syndrome after etanercept treatment.
    Sandhu C; Chesney A; Piliotis E; Buckstein R; Koren S
    J Rheumatol; 2007 Jan; 34(1):241-2. PubMed ID: 17216706
    [No Abstract]   [Full Text] [Related]  

  • 33. Etanercept-associated SLE with lupus nephritis.
    Neradová A; Stam F; van den Berg JG; Bax WA
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract]   [Full Text] [Related]  

  • 34. Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis.
    Chainani-Wu N; Chang C; Gross AJ; Yom SS; Silverman S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):e261-3. PubMed ID: 24528797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe pancytopenia following etanercept administration in rheumatoid arthritis.
    Martínez Santana V; Izquierdo Navarro M; Calleja Hernández MÁ; Sánchez Sánchez T; Sainz Gil M
    Int J Rheum Dis; 2012 Aug; 15(4):e78-9. PubMed ID: 22898233
    [No Abstract]   [Full Text] [Related]  

  • 36. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
    Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
    Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
    Bout-Tabaku S; Rivas-Chacon R; Restrepo R
    J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of statistical analysis in open extension studies.
    Yazici Y; Yazici H
    J Rheumatol; 2006 Feb; 33(2):437; author reply 437-8. PubMed ID: 16465682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.